Log in to save to my catalogue

Comparison of the safety profile of tofacitinib and etanercept in rheumatoid arthritis patients aged...

Comparison of the safety profile of tofacitinib and etanercept in rheumatoid arthritis patients aged...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_32552_2024_ActaMedica_1040

Comparison of the safety profile of tofacitinib and etanercept in rheumatoid arthritis patients aged 60 years and over: The real-life data from the HUR-BIO registry

About this item

Full title

Comparison of the safety profile of tofacitinib and etanercept in rheumatoid arthritis patients aged 60 years and over: The real-life data from the HUR-BIO registry

Publisher

Akdema Informatics and Publishing

Journal title

Acta Medica, 2024-09, Vol.55 (3), p.215-222

Language

English

Formats

Publication information

Publisher

Akdema Informatics and Publishing

More information

Scope and Contents

Contents

Objective: To investigate the safety profile of tofacitinib in rheumatoid arthritis (RA) patients aged 60 and over and to compare these findings with etanercept.
Materials and methods: HUR-BIO (Hacettepe University Rheumatology Biologic Registry) is a single-center registry for biological and targeted synthetic DMARDs since 2005. We included RA...

Alternative Titles

Full title

Comparison of the safety profile of tofacitinib and etanercept in rheumatoid arthritis patients aged 60 years and over: The real-life data from the HUR-BIO registry

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_crossref_primary_10_32552_2024_ActaMedica_1040

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_32552_2024_ActaMedica_1040

Other Identifiers

ISSN

2147-9488

E-ISSN

2147-9488

DOI

10.32552/2024.ActaMedica.1040

How to access this item